Clinical Review & Education JAMA | Review Cardiogenic Shock After Acute Myocardial Infarction A Review Marc D. Samsky, MD; David A. Morrow, MD, MPH; Alastair G. Proudfoot, MBChB, PhD; Judith S. Hochman, MD; Holger Thiele, MD; Sunil V. Rao, MD Supplemental...
More
Clinical Review & Education JAMA | Review Cardiogenic Shock After Acute Myocardial Infarction A Review Marc D. Samsky, MD; David A. Morrow, MD, MPH; Alastair G. Proudfoot, MBChB, PhD; Judith S. Hochman, MD; Holger Thiele, MD; Sunil V. Rao, MD Supplemental content IMPORTANCE Cardiogenic shock affects between 40 000 and 50 000 people CME Quiz at in the US per year and is the leading cause of in-hospital mortality following acute jamacmelookup.com myocardial infarction. OBSERVATIONS Thirty-day mortality for patients with cardiogenic shock due to myocardial infarction is approximately 40%, and 1-year mortality approaches 50%. Immediate revascularization of the infarct-related coronary artery remains the only treatment for cardiogenic shock associated with acute myocardial infarction supported by randomized clinical trials. The Percutaneous Coronary Intervention Strategies with Acute Myocardial Infarction and Cardiogenic Shock (CULPRIT-SHOCK) clinical trial demonstrated a reduction in the p
Less
